143 related articles for article (PubMed ID: 27870826)
21. Biochemical markers of recombinant human insulin-like growth factor-I (rhIGF-I)/rhIGF binding protein-3 (rhIGFBP-3) misuse in athletes.
Guha N; Erotokritou-Mulligan I; Nevitt SP; Francis M; Bartlett C; Cowan DA; Bassett EE; Sönksen PH; Holt RI
Drug Test Anal; 2013; 5(11-12):843-9. PubMed ID: 24173773
[TBL] [Abstract][Full Text] [Related]
22. Recombinant human insulin-like growth factor (IGF)-binding protein-1 inhibits somatic growth stimulated by IGF-I and growth hormone in hypophysectomized rats.
Cox GN; McDermott MJ; Merkel E; Stroh CA; Ko SC; Squires CH; Gleason TM; Russell D
Endocrinology; 1994 Nov; 135(5):1913-20. PubMed ID: 7525258
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of recombinant human IGF-1/IGFBP-3 on intraventricular hemorrhage prevention and survival in the preterm rabbit pup model.
Ekström C; Ortenlöf N; Kristiansson A; Holmqvist B; Jungner Å; Vallius S; Wang X; Hellström A; Barton N; Carey G; Ley D; Gram M
Sci Rep; 2023 Nov; 13(1):19847. PubMed ID: 37963901
[TBL] [Abstract][Full Text] [Related]
24. Provision of rhIGF-I/IGFBP-3 complex attenuated development of cancer cachexia in an experimental tumor model.
Wang W; Iresjö BM; Karlsson L; Svanberg E
Clin Nutr; 2000 Apr; 19(2):127-32. PubMed ID: 10867731
[TBL] [Abstract][Full Text] [Related]
25. Assessment of compatibility of rhIGF-1/rhIGFBP-3 with neonatal intravenous medications.
Salamat-Miller N; Turner MA; Bandekar A; Dixit N; Jochim E; Mangum B; McPherson C; Tenjarla S; Singh S; Hwang YS; Barton N
World J Pediatr; 2023 Jan; 19(1):58-67. PubMed ID: 36344872
[TBL] [Abstract][Full Text] [Related]
26. Characterization of choroid plexus in the preterm rabbit pup following subcutaneous administration of recombinant human IGF-1/IGFBP-3.
Ortenlöf N; Vallius S; Karlsson H; Ekström C; Kristiansson A; Holmqvist B; Göransson O; Vaváková M; Rydén M; Carey G; Barton N; Ley D; Gram M
Fluids Barriers CNS; 2023 Aug; 20(1):59. PubMed ID: 37582792
[TBL] [Abstract][Full Text] [Related]
27. IGF-I in the clinics: Use in retinopathy of prematurity.
Hellström A; Ley D; Hansen-Pupp I; Hallberg B; Ramenghi LA; Löfqvist C; Smith LE; Hård AL
Growth Horm IGF Res; 2016; 30-31():75-80. PubMed ID: 27720550
[TBL] [Abstract][Full Text] [Related]
28. Recombinant human insulin-like growth factor binding protein-3 (rhIGFBP-3): effects on the glycemic and growth promoting activities of rhIGF-1 in the rat.
Clark RG; Mortensen D; Reifsynder D; Mohler M; Etcheverry T; Mukku V
Growth Regul; 1993 Mar; 3(1):50-2. PubMed ID: 7683530
[TBL] [Abstract][Full Text] [Related]
29. Musculoskeletal effects of the recombinant human IGF-I/IGF binding protein-3 complex in osteoporotic patients with proximal femoral fracture: a double-blind, placebo-controlled pilot study.
Boonen S; Rosen C; Bouillon R; Sommer A; McKay M; Rosen D; Adams S; Broos P; Lenaerts J; Raus J; Vanderschueren D; Geusens P
J Clin Endocrinol Metab; 2002 Apr; 87(4):1593-9. PubMed ID: 11932288
[TBL] [Abstract][Full Text] [Related]
30. Effects of recombinant human insulin-like growth factor I (IGF-I) therapy on the growth hormone-IGF system of a patient with a partial IGF-I gene deletion.
Camacho-Hübner C; Woods KA; Miraki-Moud F; Hindmarsh PC; Clark AJ; Hansson Y; Johnston A; Baxter RC; Savage MO
J Clin Endocrinol Metab; 1999 May; 84(5):1611-6. PubMed ID: 10323388
[TBL] [Abstract][Full Text] [Related]
31. Serum insulin-like growth factor I (IGF-I), IGF-binding proteins-1 and -3, and postnatal growth of late preterm infants.
Giapros VI; Schiza V; Challa AS; Pantou C; Theocharis PD; Andronikou SK
Horm Metab Res; 2012 Oct; 44(11):845-50. PubMed ID: 22791601
[TBL] [Abstract][Full Text] [Related]
32. Long-term effect of recombinant human insulin-like growth factor I on metabolic and growth control in a patient with leprechaunism.
Nakae J; Kato M; Murashita M; Shinohara N; Tajima T; Fujieda K
J Clin Endocrinol Metab; 1998 Feb; 83(2):542-9. PubMed ID: 9467572
[TBL] [Abstract][Full Text] [Related]
33. Retinopathy of Prematurity: Therapeutic Strategies Based on Pathophysiology.
Cayabyab R; Ramanathan R
Neonatology; 2016; 109(4):369-76. PubMed ID: 27251645
[TBL] [Abstract][Full Text] [Related]
34. Recovery of growth hormone release from suppression by exogenous insulin-like growth factor I (IGF-I): evidence for a suppressive action of free rather than bound IGF-I.
Chapman IM; Hartman ML; Pieper KS; Skiles EH; Pezzoli SS; Hintz RL; Thorner MO
J Clin Endocrinol Metab; 1998 Aug; 83(8):2836-42. PubMed ID: 9709956
[TBL] [Abstract][Full Text] [Related]
35. Two-year treatment of growth hormone (GH) receptor deficiency with recombinant insulin-like growth factor I in 22 children: comparison of two dosage levels and to GH-treated GH deficiency.
Guevara-Aguirre J; Rosenbloom AL; Vasconez O; Martinez V; Gargosky SE; Allen L; Rosenfeld RG
J Clin Endocrinol Metab; 1997 Feb; 82(2):629-33. PubMed ID: 9024266
[TBL] [Abstract][Full Text] [Related]
36. Co-administration of insulin-like growth factor (IGF)-I and IGF-binding protein-1 stimulates wound healing in animal models.
Tsuboi R; Shi CM; Sato C; Cox GN; Ogawa H
J Invest Dermatol; 1995 Feb; 104(2):199-203. PubMed ID: 7530269
[TBL] [Abstract][Full Text] [Related]
37. Fresh-frozen plasma as a source of exogenous insulin-like growth factor-I in the extremely preterm infant.
Hansen-Pupp I; Engström E; Niklasson A; Berg AC; Fellman V; Löfqvist C; Hellström A; Ley D
J Clin Endocrinol Metab; 2009 Feb; 94(2):477-82. PubMed ID: 19001522
[TBL] [Abstract][Full Text] [Related]
38. Effects of insulin-like growth factor I (IGF-I) therapy on body composition and insulin resistance in IGF-I gene deletion.
Woods KA; Camacho-Hübner C; Bergman RN; Barter D; Clark AJ; Savage MO
J Clin Endocrinol Metab; 2000 Apr; 85(4):1407-11. PubMed ID: 10770174
[TBL] [Abstract][Full Text] [Related]
39. Mecasermin rinfabate: rhIGF-I/rhIGFBP-3 complex: iPLEX.
Williams RM; McDonald A; O'Savage M; Dunger DB
Expert Opin Drug Metab Toxicol; 2008 Mar; 4(3):311-24. PubMed ID: 18363546
[TBL] [Abstract][Full Text] [Related]
40. Open-label trial of recombinant human insulin-like growth factor 1/recombinant human insulin-like growth factor binding protein 3 in myotonic dystrophy type 1.
Heatwole CR; Eichinger KJ; Friedman DI; Hilbert JE; Jackson CE; Logigian EL; Martens WB; McDermott MP; Pandya SK; Quinn C; Smirnow AM; Thornton CA; Moxley RT
Arch Neurol; 2011 Jan; 68(1):37-44. PubMed ID: 20837825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
